Fighting Cancer

Every Step of the Way

Vigilant Biosciences is transforming the early detection and intervention of cancer.

Learn More
Media Kit
vb-homepage-image3

Dedicated to Early Intervention. And Life.


Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection and intervention of cancer. Its OncAlert™ Oral Cancer System uses patented technology that is highly-accurate and specific.

Learn More
Did You Know?

When diagnosed early, oral cancer patients have an 80 to 90% survival rate.

Unfortunately, over 40% of those diagnosed with oral cancer will die within five years due to these cases being discovered as a late stage malignancy.

Learn More

At A Glance

Transforming Early Detection

Vigilant Biosciences’ products are based on patented technology that detects specific protein markers known to clinically show elevated risk for early stage cancers, even prior to observation of visual or physical symptoms... more


Easy-to-Use and Non-Invasive

OncAlert™ products utilize a simple oral rinse procedure that is easy to administer and non-invasive for the patient... more


Accurate and Objective Results at the Point-of-Care or Lab

Both the rapid point-of-care test and the lab assay that comprise the OncAlert™ System provide a timely, accurate, and specific risk assessment for oral cancer... more

MORE ABOUT VIGILANT'S ONCALERT™ TECHNOLOGY

News + Press

  • logo

    National Consumer Survey Reveals Greater Need for Oral Cancer Education and Prevention

    This year alone, more than 600,000 new cases of oral cancer will be detected worldwide, including over 48,000 Americans. In the U.S. this year, there will be 9570 deaths from this disease—roughly 1 person per hour, every day. This is…more

  • dentistry-today

    Statistics Alone Don’t Reveal Oral Cancer’s Terrible Toll

    While many of us may have heard the horrific statistics associated with oral cancer, the personal stories behind those figures often go overlooked. By the Numbers More than 600,000 cases of oral and oropharyngeal cancer are diagnosed each year worldwide,…more

  • Screen Shot 2015-09-08 at 12.56.25 PM

    National Oral Cancer Awareness Survey Reveals Shocking Statistics

    A recent national consumer survey released by Vigilant Biosciences revealed that among U.S. adults, the majority knows very little or nothing at all about oral cancer (58 percent) and only 37 percent reported being screened for oral cancer at their…more

  • OHlogo

    Oral Cancer Awareness Survey Shows Lack of Awareness, Greater Need for Education & Screening

    A recent national consumer survey revealed that among U.S. adults, the majority knows very little or nothing at all about oral cancer (58 percent) and only 37 percent reported being screened for oral cancer at their last dental check-up, according…more


©2011-2016 Vigilant Biosciences, Inc. All Rights Reserved.

×